Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Aktuelles, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2023-10-19 / Methods Cell Biol 2024;183:51-113Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment
/in Dendritic Cells, International Publications, NSCLC /von 2023-10-04 / Cells 2023 Oct;12(19)Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2023-10-02 / Front Immunol 2023;14:1241949Combination therapy with dendritic cell loaded-exosomes supplemented with PD-1 inhibition at different time points have superior antitumor effect in hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2023-09-04 / Cancer Immunol Immunother 2023 Nov;72(11):3727-3738Breast cancer immunotherapy: a comprehensive review
/in Breast Cancer, Dendritic Cells, International Publications /von 2023-09-01 / Clin Exp Med 2023 Dec;23(8):4431-4447Cancer Vaccine Therapeutics: Limitations and Effectiveness-A Literature Review
/in Dendritic Cells, International Publications /von 2023-08-28 / Cells 2023 Aug;12(17)A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2023-08-12 / Vaccines (Basel) 2023 Aug;11(8)Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors
/in Dendritic Cells, Hypernephroma, International Publications /von 2023-08-11 / Int Immunopharmacol 2023 Oct;123:110722Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2023-07-31 / Cancers (Basel) 2023 Jul;15(15)
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de